These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 12746699

  • 1. [Medical treatment of spasticity].
    Rode G, Maupas E, Luaute J, Courtois-Jacquin S, Boisson D.
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):247-55. PubMed ID: 12746699
    [Abstract] [Full Text] [Related]

  • 2. [Orally administered drugs in the treatment of spasticity].
    Campistol J.
    Rev Neurol; 2003 May; 37(1):70-4. PubMed ID: 12861514
    [Abstract] [Full Text] [Related]

  • 3. Traditional pharmacological treatments for spasticity. Part II: General and regional treatments.
    Gracies JM, Nance P, Elovic E, McGuire J, Simpson DM.
    Muscle Nerve Suppl; 1997 May; 6():S92-120. PubMed ID: 9826984
    [Abstract] [Full Text] [Related]

  • 4. A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis.
    Smolenski C, Muff S, Smolenski-Kautz S.
    Curr Med Res Opin; 1981 May; 7(6):374-83. PubMed ID: 7016449
    [Abstract] [Full Text] [Related]

  • 5. Comparative profile of tizanidine in the management of spasticity.
    Lataste X, Emre M, Davis C, Groves L.
    Neurology; 1994 Nov; 44(11 Suppl 9):S53-9. PubMed ID: 7970011
    [Abstract] [Full Text] [Related]

  • 6. Pharmacotherapy of spasticity in children with cerebral palsy.
    Verrotti A, Greco R, Spalice A, Chiarelli F, Iannetti P.
    Pediatr Neurol; 2006 Jan; 34(1):1-6. PubMed ID: 16376270
    [Abstract] [Full Text] [Related]

  • 7. Managing spasticity with drugs.
    Simon O, Yelnik AP.
    Eur J Phys Rehabil Med; 2010 Sep; 46(3):401-10. PubMed ID: 20927006
    [Abstract] [Full Text] [Related]

  • 8. Principles of pharmaceutical management of spastic hypertonia.
    Elovic E.
    Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):793-816, vii. PubMed ID: 11727721
    [Abstract] [Full Text] [Related]

  • 9. [Intrathecal baclofen. Experimental and pharmacokinetic studies].
    Sallerin B, Lazorthes Y.
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):271-5. PubMed ID: 12746702
    [Abstract] [Full Text] [Related]

  • 10. [Assessment of spasticity therapy with baclofen pump in children].
    Swierczyńska A.
    Przegl Lek; 2007 May; 64 Suppl 2():15-7. PubMed ID: 17953273
    [Abstract] [Full Text] [Related]

  • 11. Tizanidine treatment of spasticity: a meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam.
    Groves L, Shellenberger MK, Davis CS.
    Adv Ther; 1998 May; 15(4):241-51. PubMed ID: 10186943
    [Abstract] [Full Text] [Related]

  • 12. Physiologic and pharmacologic approaches to spasticity.
    Young RR.
    Neurol Clin; 1987 Nov; 5(4):529-39. PubMed ID: 3323874
    [Abstract] [Full Text] [Related]

  • 13. Intrathecal clonidine for controlling spastic hypertonia.
    Rémy-Néris O, Denys P, Bussel B.
    Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):939-51, ix. PubMed ID: 11723871
    [Abstract] [Full Text] [Related]

  • 14. An approach to switching patients from baclofen to tizanidine.
    Brenner R, Hyman N, Knobler R, O'Brien M, Stephan T.
    Hosp Med; 1998 Oct; 59(10):778-82. PubMed ID: 9850294
    [Abstract] [Full Text] [Related]

  • 15. [The usefulness of tizanidine. A one-year follow-up of the treatment of spasticity in infantile cerebral palsy].
    Vásquez-Briceño A, Arellano-Saldaña ME, León-Hernández SR, Morales-Osorio MG.
    Rev Neurol; 1998 Oct; 43(3):132-6. PubMed ID: 16871477
    [Abstract] [Full Text] [Related]

  • 16. Pharmacologic interventions for reducing spasticity in cerebral palsy.
    Patel DR, Soyode O.
    Indian J Pediatr; 2005 Oct; 72(10):869-72. PubMed ID: 16272661
    [Abstract] [Full Text] [Related]

  • 17. Spasticity: revisiting the role and the individual value of several pharmacological treatments.
    Lapeyre E, Kuks JB, Meijler WJ.
    NeuroRehabilitation; 2010 Oct; 27(2):193-200. PubMed ID: 20871149
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group.
    Nance PW, Bugaresti J, Shellenberger K, Sheremata W, Martinez-Arizala A.
    Neurology; 1994 Nov; 44(11 Suppl 9):S44-51; discussion S51-2. PubMed ID: 7970010
    [Abstract] [Full Text] [Related]

  • 19. [Intrathecal baclofen in the treatment of severe spastic tetraplegia and dystonia in children and adolescents].
    Illum NO, Hansen FJ, Fischer C, Uldall PV, Nielsen OA.
    Ugeskr Laeger; 2003 Apr 21; 165(17):1755-9. PubMed ID: 12768902
    [Abstract] [Full Text] [Related]

  • 20. [Management of spasticity in children with cerebral palsy].
    Matthews DJ, Balaban B.
    Acta Orthop Traumatol Turc; 2009 Apr 21; 43(2):81-6. PubMed ID: 19448346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.